The requirement for notch signaling during vascular development is well-documented but poorly understood. Embryonic and adult endothelial cells (EC) express notch and notch ligands; however, the necessity for cell-autonomous notch signaling during angiogenesis has not been determined. During angiogenesis, EC display plasticity, whereby a subset of previously quiescent cells loses polarity and becomes migratory. To investigate the role of notch in EC, we have used a three-dimensional in vitro system that models all of the early steps of angiogenesis. We find that newly forming sprouts are composed of specialized tip cells that guide the sprout and trunk cells that proliferate and rearrange to form intercellular lumens. Furthermore, we find that notch acts cell-autonomously to suppress EC proliferation, thereby regulating tube diameter. In addition, when notch signaling is blocked, tip cells divide, and both daughter cells take on a tip cell phenotype, resulting in increased branching through vessel bifurcation. In contrast, notch signaling is not required for re-establishment of EC polarity or for lumen formation. Thus, notch is used reiteratively and cell-autonomously by EC to regulate vessel diameter, to limit branching at the tip of sprouts, and to establish a mature, quiescent phenotype.
Delta4 is expressed in arterial, but not venular, endothelium (5, 11) . It is important that only Notch4 and Delta4 are expressed in capillaries (5) , the likely source of angiogenic sprouts. Overexpression of a constitutively active form of Notch4 in the vasculature of mice results in defective embryonic angiogenesis, especially in the brain (12) . In addition, the human cardiovascular diseases, cerebral autosomal dominant arteriopathy and subcortical infarcts and leukoencephalopathy (CADASIL) and Alagille syndrome, have been associated with mutations in the Notch3 gene and Jagged1 gene, respectively (13) . Our own data have demonstrated that the basic helix-loop-helix (bHLH) transcription factor hairy and enhancer of split related 1 (HESR1) is a downstream target of notch in EC and that it is essential for EC network formation in collagen gels (14, 15) . Based on these in vitro studies, we have proposed that notch is necessary for the establishment and/or maintenance of the quiescent EC phenotype, analogous to its role in regulating epithelial cell plasticity (4, 16, 17) . Recently, HESR1 and HESR2 (also known as HEY1 and HEY2) were knocked out in mice, and the double-knockout proved to be embryonic-lethal with severe vascular defects, including lack of remodeling and massive hemorrhage (18) . It is important, however, that HESR1 can be activated independently of notch (19) , and notch can signal independently of HESR1.
Notch has also been implicated in EC arterio-venous fate specification in zebrafish (20, 21) , although the story may be more complicated in mice (22) . These studies clearly demonstrate that notch and the notch targets HESR1 and HESR2 are required for proper embryonic vascular development. However, these in vivo studies have not established whether the requirement for notch is cell-autonomous or nonautonomous with regard to EC nor have they addressed the role of notch in adult angiogenesis.
The notch receptor is activated when engagement by one of its ligands on an adjacent cell triggers a series of cleavages that releases the notch intracellular domain (NotchIC; refs 2, 23). Processing of the notch proteins requires the activity of two proteases, namely tumor necrosis factor α-converting enzyme and presenilin/γ-secretase, which cleave the receptor between the extracellular and transmembrane domains and within the transmembrane domain, respectively. NotchIC then acts via CBF1, Su(H), and Lag-1/recombination signal sequence-binding protein (RBP)-j/Su(H) to induce expression of genes of the HES/E(spl) and HESR families (24, 25).
As is the case for many genes, notch is used reiteratively throughout development, and so, the use of knockout mice will not provide information on gene function subsequent to the time at which loss of that gene is lethal. Moreover, it is not possible to determine from such studies whether notch signaling is required in the EC themselves (cell autonomous) or is necessary for function of support cells, such as pericytes or smooth muscle cells (SMC), which make contact with the EC in vivo. In addition, a recent publication has suggested that embryonic and adult neovascularization are different processes regulated by different mechanisms (26). Thus, it can be argued that notch may play a different role during vascular plexus remodeling (a common failure point in notch mutants) and during sprouting angiogenesis occurring in adult tissues and in tumors. For these reasons, we have chosen to study EC notch signaling using a recently optimized, three-dimensional (3D) in vitro tubulogenesis assay (27), where EC-specific roles for notch in vascular growth and development can be revealed. This system faithfully reproduces most of the early steps in angiogenesis, including EC sprouting, proliferation, alignment, tube formation, branching, anastomosis, and synthesis of a new basement membrane. It is becoming increasingly appreciated that compared with 2D culture, 3D culture systems offer considerably greater fidelity to the environment than most cells inhabit in vivo and that complex phenotypes are often not manifested in 2D systems (28-31).
Using this model, we have previously demonstrated that tube diameter is directly dependent on vascular endothelial growth factor (VEGF)-driven proliferation of EC (32). We have also shown that the VEGF receptor VEGFR2 is a downstream target of notch signaling in EC (14, 15) , and others have shown notch to be downstream of VEGF in zebrafish (33) and in cultured, arterial EC (34) . These studies, together with findings in drosophila suggesting that notch-ligand interactions may be involved in defining the "tip cell" phenotype in developing trachea (35) , led us to ask whether notch might have multiple roles in patterning developing vascular sprouts beyond what has been inferred from in vivo studies. In the present study, we provide evidence that cell autonomous notch signaling in EC plays a major role in regulating EC phenotype and that vessel diameter and vessel branching are under the control of this signaling pathway.
MATERIALS AND METHODS

Cell culture and reagents
Human umbilical vein endothelial cells (HUVEC) were isolated and maintained as described previously (27) . Only HUVEC between P3 and P4 were used for these experiments. Skin fibroblasts (Detroit-551) were purchased from the American Type Culture Collection (Rockville, MD, USA) and used between P13 and P20. The γ-secretase inhibitor (GSI) L-685,458 was purchased from Calbiochem (San Diego, CA, USA) as a 1-mM solution in dimethyl sulfoxide (DMSO) and was used at a final concentration of 2 µM. The 17-mer JAG-1 peptide (CDDYYYGFGCNKFCRPR), corresponding to amino acids 187-203 of human Jagged1 (accession number: NP_000205), was described previously and was shown to activate notch signaling in keratinocytes and myeloid cell lines (36, 37) . The scrambled peptide (SC)-JAG-1 (RCGPDCFDNYGRYKYCF) was used as a negative control. Both peptides were synthesized by Anaspec (San Jose, CA, USA). Peptides were dissolved in DMSO (50 mM), aliquoted, and stored at -20°C. Further dilutions to 100 µM were carried out at the time of the experiments.
Plasmids, antisense oligonucleotides, and cell transfection
The human cDNA coding for Notch1 epidermal growth factor (EGF) motifs 11/12 was amplified by polymerase chain reaction (PCR) using a HUVEC cDNA library and the following primers:
upper-5′-GGGGACAAGTTTGTACAAAAAAGCAGGCTTGATGCAGGACGTGGATGAGTG-3′ lower-5′-GGGGACCACTTTGTACAAGAAAGCTGGGTTGTTGACCTCGCAGTGCACACC-3′.
The resulting fragment was cloned in frame at the 5′ end of a mouse immunoglobulin G (IgG)2A-Fc target vector using Gateway Cloning Technology (Invitrogen, San Diego, CA, USA) to produce the Notch1EC-Ig vector. Secretion of the recombinant proteins was ensured by addition of a signal peptide to the N terminus of the Notch1EC moiety. The phosphorylated RBPluciferase (Luc) plasmid, containing multimerized RBPj-binding sites driving luciferase, was a gift from Dr. Zimber-Strobl (38) . The antisense oligonucleotides were synthesized and characterized by Isis Pharmaceuticals (Carlsbad, CA, USA). The antisense sequences are as follows: Notch1: GCCCTCCATGCTGGCACAGG (Isis 226844) and Notch4: CGTCCAGGTGGGCAGAGGCA (Isis 141615). As a negative control, a random 20-mer oligonucleotide was used (Isis 29848). These oligonucleotides have a phosphorothioate backbone and a 2′ methoxyethyl ribose on the first five and last five nucleotides. HUVEC transfection has been described previously (27). Transfection efficiency was usually above 70% as determined by fluorescein-activated cell sorter analysis with a green fluorescent protein-expressing vector (data not shown).
Angiogenesis assays
Collagen gel assay
The in vitro collagen network-forming assays were carried out in six-well plates as described previously (15) . For luciferase assays, cells were collected at 16-18 h by digestion of the gel with 1% collagenase.
Fibrin gel bead assay
The fibrin gel bead assay was described previously in detail (27). This assay, which was optimized from a previously described method (39) , allows the use of HUVEC and the generation of clear patent lumens. Where indicated, the number of tip cells was counted; this represents the sum of primary, secondary, etc., branching.
Reverse transcriptase (RT)-PCR and quantitative PCR (qPCR) analysis
Total RNA extraction and cDNA synthesis protocols were described previously (27). PCR was performed using Taq polymerase (Invitrogen) for 30 cycles at annealing temperatures of 62°C for Delta4 and 63.5°C for glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The primer sequences and expected fragment sizes were:
Delta4 upper 5′-GCCGGGTACCTTCTCGCTCATCATC-3′, lower 5′-GCCTCCCCAGCCCTCATCACAAGTA-3′ (502 bp); GAPDH upper 5′-ACCACAGTCCATGCCATCAC-3′, lower 5′-TCCACCACCCTGTTGCTGTA-3′ (450 bp).
qPCR analysis was performed as described previously (40) . The primer sequences were as follows:
HES-1 upper 5′-CTGGAGAGGCGGCTAAGGTGTTT-3′, lower 5′-GTGCCGCTGTTGCTGGTGTAGA-3′; GAPDH upper 5′-TCGACAGTCAGCCGCATCTTCTT-3′, lower 5′-GCGCCCAATACGACCAAATCC-3′.
Proliferation assay by bromodeoxyuridine (BrdU) labeling
HUVEC on beads were cultured for 4-8 days and then incubated in the presence of 20 µM BrdU for 3 h (Roche, Indianapolis, IN, USA). The gels were then washed, and the skin fibroblasts were removed from the wells by trypsinization (5 mg/mL) for 30 s. Gels were then fixed in 70% ethanol/30% glycine solution (50 mM, pH 2.0) for 45 min, and DNA was denatured by a 15-min incubation in 4 N HCl. After blocking in 0.5% bovine serum albumin (BSA), 0.1% Tween-20, for 30 min, BrdU incorporation was detected using a fluorescein isothiocyanate (FITC)-conjugated mouse anti-BrdU antibody (clone 3D4, BD Biosciences, San Jose, CA, USA), diluted 1/500 in blocking solution. As a negative control, a FITC-conjugated mouse IgG1 monoclonal antibody (clone MOPC-21, BD Biosciences) was used at the same concentration. Control staining was consistently negative (data not shown).
Fluorescent staining
In-gel fluorescence staining was carried out after skin fibroblast removal at the indicated time. Cultures were fixed 10 min in 10% formalin and permeabilized with 0.5% Triton X-100 for 5 min. Nonspecific binding was blocked using a solution of 5% BSA in phosphate-buffered saline for 2 h. For nuclear staining, 4,6-diamidineo-2-phenylindole (DAPI; Sigma Chemical Co., St. Louis, MO, USA) was used at a concentration of 1 µg/ml. F-actin was stained using tetramethylrhodamine isothiocyanate (TRITC)-phalloidin (Sigma Chemical Co.) at a concentration of 0.2 µM. Antibodies for β-catenin (rabbit polyclonal) and collagen IV (mouse monoclonal, Clone Col-94) were used at a 1/100 dilution in blocking solution and were purchased from Cell Signaling Technology (Beverly, MA, USA) and Sigma Chemical Co., respectively. The samples were incubated under agitation with the primary antibodies overnight at 4°C. After washing, labeling was detected using an Alexa Fluor 488-conjugated anti-mouse and an Alexa Fluor 568 conjugated anti-rabbit (1/1000 dilutions, Molecular Probes, Junction City, OR, USA). Isotype-specific, nonbinding antibodies were used as a control and were consistently negative (data not shown). Phase contrast and fluorescence images of beads were captured on an IX70 Olympus microscope (10× objective) coupled with a digital camera. Images were then analyzed using National Institutes of Health (NIH; Bethesda, MD, USA) ImageJ. Two-photon fluorescence images were captured on a Carl Zeiss MicroImaging Corp. (Thornwood, NY, USA) LSM 510 Meta microscopic system (10× and 20× objective).
Time-lapse video microscopy
HUVEC-coated beads were cultured for 4 days and then transferred to the stage of a Nikon Eclipse TE300, equipped with multidimensional x-, y-, and z-axis and maintained at 37°C and 5% CO 2 for 72 h. Images were acquired every 20 min using Metamorph software (Universal Imaging Corp., Downingtown, PA, USA) and stored as TIFF files.
Statistical analysis
The differences between experimental groups were analyzed using Student's t test, and P < 0.05 was considered significant.
RESULTS
The γ-secretase inhibitor L-685,458 blocks notch signaling in EC Notch processing following ligand binding and subsequent translocation of the transcriptionally active intracellular domain into the nucleus is dependent on presenilin/γ-secretase activity. The protease activity can be blocked by the GSI L-685,458, which results in the inhibition of notch signaling. Other targets for γ-secretase have also been identified (see below). To confirm the inhibition of notch signaling in EC by GSI, we assayed for inhibition of the notch reporter construct RBP-Luc and for disruption of EC network formation. We have previously demonstrated that this construct is responsive to notch signaling during EC network formation in 3D collagen gels (15), and we used this system again, as it provides a sensitive read-out of notch activation. Transfected cells were grown in the presence of DMSO or GSI in 2D and 3D cultures (Fig. 1A) . Blocking notch signaling with GSI had little effect in 2D cultures but significantly inhibited network formation in 3D culture, resulting in a decrease in the total network length (not shown). It is important that the notch-dependent increase in expression of luciferase that we normally see when EC are transitioned from 2D to 3D was blocked completely by GSI. In addition, low-level notch signaling in 2D cultures was also blocked by GSI.
Expression of a constitutively active form of Notch4 (Int-3) was previously shown to induce the expression of the notch ligand Delta4 (41) , suggesting that Delta4 is a notch target gene. We confirmed that this is the case in EC and found, moreover, that Delta4 expression was inhibited significantly in the presence of GSI (Fig. 1B) . We also confirmed that GSI blocked induction of the notch target gene HES-1, using qPCR (Fig. 1C) . Together, these data confirm that GSI effectively blocks notch signaling in EC.
γ-Secretase-dependent signaling regulates vessel diameter
We have previously demonstrated that VEGF concentration regulates endothelial tube diameter directly through its effects on cell proliferation (32); data are consistent with a recent report on developing vasculature in the retina (42) . In addition, we have shown that notch, acting through HESR1, down-regulates VEGFR2 expression (14, 15) . Our prediction, therefore, was that notch might also regulate vessel diameter. HUVEC-coated beads were embedded in fibrin gels in the presence of DMSO or GSI, and tubule formation was examined over a period of 8 days. As demonstrated in Fig. 2A , treatment of EC with GSI-supplemented media induced dramatic changes in tubule morphology. EC cultured in the presence of DMSO had a similar phenotype to those grown in unsupplemented media, demonstrating that the GSI-induced phenotype was not a result of the presence of DMSO. It is most notable that GSI induced the formation of larger sprouts, consistent with the increase in capillary diameter observed in mice lacking Presenilin-1 (9) . Indeed, the average sprout diameter increased ~60% following the addition of GSI (Fig. 2B ). Lumens were not so readily apparent as in control vessels, and we address this issue in more detail below. We did not detect any statistical differences in sprout length (Fig. 2B) . Thus, notch signaling limits tube diameter, likely through effects on notch signaling (see below), and appears to be antagonistic to VEGF in this system.
Notch regulates tubule diameter through suppression of cell proliferation
The increase in sprout diameter observed in the presence of GSI may be a result of an increase in cell number (cellular hyperplasia) or cell size (hypertrophy). To differentiate between these two possibilities, day-8 cultures from DMSO-and GSI-treated samples were fixed and stained with DAPI and TRITC-phalloidin (Fig. 3A) . Nuclear staining with DAPI clearly indicated that the increase in vessel diameter correlated with an increase in the number of cells present in each vessel. Quantification revealed a close-to-fourfold increase in cell number per sprout when notch signaling was blocked (Fig. 3B) . F-actin staining demonstrated an increase in projected area, which correlated with the increase in sprout diameter. It is interesting that the ratio of cell number to projected area also increased significantly, suggesting that cells are actually smaller in the presence of GSI. This observation was confirmed independently (data not shown) by calculating internuclear distance using a formula that takes into account a 3D structure (the sprout) being projected onto two dimensions (32).
The observed increase in cell number per sprout may be explained by an increase in cell proliferation, increased migration of EC from the beads, or a decrease in apoptosis. Although, notch activation in EC stable cell lines was shown to inhibit migration (43), we did not observe a statistically significant difference in primary EC migration in wound-healing experiments performed in the presence of GSI compared with DMSO (data not shown). Similarly, we ruled out a decrease in apoptosis in the presence of GSI, as live-imaging experiments did not reveal a change in the incidence of blebbing cells, a hallmark of programmed cell death, and the caspase inhibitor Z-Val-Ala-Asp was without effect (data not shown). Conversely, analysis of cell proliferation using BrdU labeling revealed a twofold increase in the number of positive cells when media was supplemented with GSI ( Fig. 3C, D) . Altogether, these experiments suggest that the increase in cell number is primarily a result of increased cell proliferation in the presence of GSI; that is, notch signaling acts to suppress proliferation as suggested previously (34) . In conclusion, inhibition of γ-secretase activity and thus, notch signaling, increases EC proliferation during sprouting, and this accounts for the increase in vessel diameter.
Although L685,458 is a specific inhibitor of γ-secretase and effectively blocks notch signaling, several new substrates for this enzyme have been described recently, such as E-cadherin and CD44 (44) . To differentiate notch-dependent from potentially notch-independent phenotypes, we repeated the above experiments using additional, specific inhibitors of notch signaling. The Notch1 extracellular domain contains an array of 36 EGF repeats, two of which, EGF repeats 11 and 12, are crucial for receptor-ligand interactions. Previous studies have demonstrated that NotchEC-EGF11/12 blocks receptor-ligand interactions and therefore interferes with the signaling process (45) . An EGF repeat/Ig-Fc fusion protein construct, Notch1EC-Ig, was constructed and transfected into EC, and expression of the recombinant protein was confirmed in the cell extract and in the medium by Western blotting using an anti-mouse-Fc antibody (Fig.  4A) . To test functionality of the protein, we again used the collagen gel assay in combination with RBP-Luc-transfected EC. Notch signaling was strongly induced when EC were transitioned from 2D to 3D, and this was blocked effectively by coexpression of Notch1EC-Ig (Fig. 4B) .
We then examined the effect of Notch1EC-Ig expression in the fibrin bead assay. As these experiments were performed using transient transfection, tubulogenesis was only followed over a period of 4 days to minimize the effect of transgene loss. In agreement with our previous experiments, where we blocked notch signaling with GSI, the use of Notch1EC-Ig was also effective in increasing cell proliferation, as shown by a 70% increase in the number of BrdUpositive cells per sprout (Fig. 4C) .
As a third strategy to block notch signaling, we knocked down the expression of Notch1 and Notch4 using specific antisense oligonucleotides. We used mixed-backbone molecules to maximize solubility and resistance to nuclease digestion (see Materials and Methods). Specificity and efficacy were confirmed by RT-PCR (E. Koller, Isis Pharmaceuticals, unpublished data). EC were transfected with the oligonucleotides using lipofectamine and then coated onto beads. In agreement with our Notch1EC-Ig data, antisense to Notch1 or Notch4 also increased the number of BrdU-positive cells/sprout two-to threefold when compared with the scrambled sequence (Fig. 4D) . The combination of Notch1 and Notch4 antisense had no additive effect (not shown). Taken together, the GSI data, the Notch1EC-Ig data, and the antisense data confirm that in vascular organotypic 3D cultures, notch signaling acts to suppress EC proliferation, thereby limiting tubule diameter.
Notch suppresses branching at the tip of a developing sprout
Angiogenic capillary sprouts are composed of cells of distinct phenotype (46, 47) . Trunk cells proliferate and contribute to lumen formation, and the lead or tip cell does not form a lumen and in retina, has been reported to not divide (42) . The tip cell is, however, highly motile and extends numerous processes into the surrounding matrix. Its behavior is reminiscent of neuronal growth cones, and indeed, "neural guidance" genes such as neural cell adhesion molecule and neuropilin-1 are expressed in angiogenic EC (28, 48). We noted a second phenotype induced by GSI treatment of bead cultures: an increased number of secondary branches, the majority of them appearing to be bifurcations at the tips of developing sprouts as a result of tip cell duplication (Fig. 5A) . To determine whether this was indeed the case, we examined sprout development in the presence of GSI by time-lapse videomicroscopy. As can be seen in Fig. 5Bc , a tip has bifurcated, and one of these branches then extends more rapidly than the other (Fig. 5Bd) . Another example of bifurcation is shown in Fig. 5Bg . Branching from the trunk of sprouts was also apparent (Fig. 5Bb) . When these assays were quantified, we observed that the degree of branching (measured by number of vessel tips) was dramatically increased in GSI-treated samples, up to four-to fivefold by day 6 (Fig. 5C ). It is interesting that when proliferation assays were carried out using BrdU incorporation, we were able to demonstrate that this increase in branching also correlates with a high incidence of tip cell divisions in cultures supplemented with GSI (Fig. 5D ).
To confirm that the effects of GSI on sprouting were notch-specific, we again used Notch1EC-Ig-transfected cells as well as antisense against Notch1 and Notch4 transcripts. In agreement with our GSI data, suppression of notch signaling using these approaches also augmented sprouting by two-to fourfold (Fig. 6A, B) . As a result of the transient effects of antisense and the extinction of expression from the transfected plasmid, we were only able to assess early (3-4 days) sprouting using these methods.
Activation of notch signaling with a JAG-1 peptide blocks sprouting
Previous studies have shown that notch signaling can be activated with a small synthetic peptide (JAG-1) corresponding only to the δ/Serrate/Lag-2 domain of Jagged1 (37) . We confirmed the ability of this peptide, but not a scrambled peptide, to augment notch signaling in 3D by using the collagen gel assay (Fig. 7A) . Addition of JAG-1 synergized with endogenous signaling induced by transition to a 3D environment to further activate notch signaling in EC. Based on our findings in the 3D bead assays that inhibition of notch signaling promoted sprouting and branching, we predicted that stimulation of notch would block sprouting. EC-coated beads were cultured in the presence of scrambled peptide or JAG-1 and assessed for sprouting at different times. As early as day 3, sprouting in the presence of JAG-1 was reduced dramatically, and maximal suppression of 80% was seen at day 6 (Fig. 7B, C) . These results, which rely on physiological processing of notch, are consistent with a report showing that overexpression of Notch4IC in EC also blocks sprouting in vitro (43) . Thus, sprouting and secondary branching are suppressed by activation of notch signaling and augmented by inhibition of signaling.
Notch signaling does not regulate lumen formation or apical-basal polarity
We took advantage of the fact that our assay induces clear lumen formation to study the effect of notch signaling during tubulogenesis (27) . Lumen formation appears to be initiated by intracellular vacuole formation in trunk cells, followed by vacuole fusion, as previously suggested (49) . However, other mechanisms appear to prevail at later times, as mature sprouts are composed of a single layer of EC, connected by adherent junctions and surrounding an intercellular lumen (Fig. 8A) . Time-lapse imaging (not shown) suggests that cord-hollowing in response to establishment of cell polarity is probably the predominant mechanism at later times (35, 50) . We noted that by phase contrast microscopy, the GSI-treated cultures often appeared to generate large sprouts that apparently lacked lumens (Fig. 8Ab) . Moreover, previous in vivo studies have demonstrated that impaired notch signaling correlates with severe defects in lumen formation of the dorsal aorta (6, 9, 18). To investigate this further, we plastic-embedded gels treated with DMSO or GSI and cut semi-thin (0.5-1.0 µm) sections and stained these with toluidine blue. We observed that GSI-treated sprouts do have lumens; however, compared with control ( Fig. 8Ac) , they were often collapsed and flattened (Fig. 8Ad) , as described previously in Notch1/Notch4 double-knockout mice (6).
The establishment of cell polarity is a critical early stage in the formation of tubular structures (50) and is a characteristic feature of epithelial cells. The establishment of apical-basal polarity in epithelial cells correlates with a mesenchyme-to-epithelial transition (MET), whereas the loss of polarity, especially in tumor progression, correlates with an epithelial-to-mesenchyme transition (EMT). Several recent studies have proposed that angiogenesis may also involve such transitions and that notch signaling may regulate part of this process (16, 17) . To determine whether sprouts in fibrin gels are composed of polarized EC, we looked at the expression of collagen IV, which is a major component of basement membranes expressed from the basal side of cells. As seen in Fig. 8B , EC that line sprouts have laid down a collagen IV-rich basement membrane, indicating that they are indeed polarized. It is interesting that where a secondary sprout is forming and along the walls of the vessel adjacent to the sprout, collagen IV is absent or greatly reduced (Fig. 8C) , consistent with a loss of polarity in tip cells and degradation of surrounding basement membrane by matrix metalloproteinases. Cultures were then established in the presence of DMSO or GSI and again, stained for collagen IV. Inhibition of notch signaling resulted in larger, flatter sprouts as seen before; however, there appeared to be no effect on expression or distribution of collagen IV (Fig. 8B) , suggesting that disruption of notch signaling does not affect establishment of apical-basal polarity in EC.
DISCUSSION
Several previous in vivo studies have noted a role for notch in the proper formation and patterning of blood vessels; however, these studies have not determined whether notch signaling is required in the EC themselves (cell autonomous), whether it is required by support cells that contact EC and provide inductive and maturation factors, or whether it is required by both. In this study, we show that notch signaling is functional in EC and find, surprisingly, that notch signaling is not absolutely required for sprouting or lumen formation. However, in the absence of notch, the patterning and branching of vessels are compromised. At least two mechanisms appear to be involved: First, signaling through notch suppresses EC proliferation, which acts to limit increases in vessel diameter; second, notch signaling limits branching by suppressing tip cell division and bifurcation of the sprout. Thus, notch is required by EC autonomously for patterning of sprouts and tubules.
The major defects noted in embryos lacking Notch1 or Notch1 and Notch4 are a failure to remodel the primary vascular plexus of the yolk sac, a failure of EC to invade the labyrinthine trophoblast layer of the developing placenta, disorganization of intersomitic vessels, and a collapsed appearance of some of the larger vessels (6) . An assessment of nonpatterned angiogenic sprouting in these embryos (as opposed to stereotypical vascular development and remodeling) has not been reported. Our results using an in vitro model, therefore, complement and build on these and other previously published in vivo studies. The in vitro model allows for the separation of direct and indirect effects of notch, as endothelial tubules form in the absence of enveloping support cells such as pericytes and SMC, which also express notch and notch ligands (51, 52) .
We have previously shown that the diameter of sprouts in 3D fibrin gel cultures is directly proportional to the concentration of VEGF and that signaling through VEGFR2 but not VEGFR1 is necessary (32). Moreover, we have shown that notch activity down-regulates VEGFR2 expression through induction of the bHLH protein HESR1 (14, 15) , which blocks VEGFR2 transcription through a noncanonical mechanism (A. M. Henderson Anderson, M. T. Holderfield, and C. C. W. Hughes, manuscript submitted). Notch has also been demonstrated to be genetically downstream of VEGF in zebrafish (33), and notch mRNA expression is induced by VEGF in cultured (2D), arterial EC (34) . These studies suggest a model that integrates VEGF and notch signaling in the regulation of vessel diameter. VEGF, acting through VEGFR2, drives EC proliferation in the developing vessel. The increase in cell number is accommodated by an increase in vessel diameter rather than vessel length, likely as a result of physical constraints (32). Notch signaling acts to counteract this proliferative drive, at least in part, by downregulating VEGFR2 expression. Notch induction by VEGF would act to complete a negative feedback loop. It is interesting that we do see a slow increase over time in notch expression in our system; however, this occurs in the continuous presence of VEGF and so, is likely induced independently. In the absence of notch or when notch signaling is blocked, an increase in EC proliferation results in a subsequent increase in vessel diameter.
Does notch also act independently of its effects on VEGFR2? It is interesting that in our previous study, where we manipulated VEGF concentration directly to affect vessel diameter, we did not see a decrease in internuclear distance, a surrogate for cell size. The finding that as cell proliferation increases in response to inhibited notch signaling, internuclear distance decreases, suggests that the growth phase of the cell cycle (G1 or G2) is shortened in the absence of notch.
These data confirm, therefore, that notch has effects on cell cycle, independent of its action on VEGFR2. Indeed, notch is known to induce the cell-cycle inhibitor p21 WAF1/CIP1 (53) . Consistent with these data, we have found that notch induces p21 (and p27) expression in 3D cultures (data not shown). It is interesting that a recent paper using retrovirally transduced EC in 2D cultures showed that p21 was down-regulated in response to notch and that notch-mediated suppression of proliferation was a result of a failure of cyclinD and cdk4 to translocate to the nucleus in the absence of p21 (54) . Perhaps relevant to this discrepancy, we have found that notch signaling in 2D and 3D is not necessarily comparable (unpublished observations). In summary, these data are consistent with a role for notch in establishment of a mature, quiescent EC phenotype (14) and consistent with a similar role for notch in epithelial development in flies (4).
As discussed above, high VEGF levels induce EC proliferation and increase vessel diameter (32); however, tip cell phenotype is unaltered, as sprouts remain limited to a single tip cell. In contrast, decreased notch signaling results in EC proliferation and tip cell duplication, suggesting that tip cell and trunk cell response to VEGF differs, as has been suggested (42); notch and VEGF act antagonistically on trunk EC proliferation; and notch signaling maintains a "differentiation border" between the tip cell and its adjacent trunk cells. Indeed, in many systems, notch regulates the fate of daughter cells after division. In the early stages of sprouting, there are two possible fate pathways that the tip cell may follow: If only a single cell initiates new vessel formation, then at some point, the tip cell will need to divide to generate a line of trunk cells. Conversely, if a second or third cell migrates out behind the tip cell and subsequently divides to generate new trunk cells, then a mechanism must exist to maintain a different phenotype between the trunk and tip cells. Notch appears to be involved in this process-an idea supported by the finding that activated Notch4 blocks sprouting angiogenesis in the brain (12) .
It has been suggested recently that notch promotes an EMT/endothelial-to-mesenchymal transformation during the transition from quiescent, tube-forming cells to migrating, proliferating cells, based on the observation that expression of activated forms of notch in cultured monolayers of EC up-regulates snail and down-regulates vascular endothelial-cadherin expression (16, 17) . The idea of an endothelial transformation builds on earlier studies showing EMT transformations of epicardial cells during valve formation in the heart (55, 56) . It is interesting that in the earliest stages of sprouting, in our cultures, lumens are absent, and cells do not synthesize collagen IV (Fig. 8C) , suggesting a loss of polarity consistent with EMT. It is remarkable that in these 3D cultures, when notch signaling was blocked, we observed an increase in expression of several "mesenchymal" markers, including c-met, α-smooth muscle actin, and snail (unpublished observations). These data are entirely consistent with the hypothesis that notch signaling promotes vessel maturation, as we (14, 15) and others (54) have suggested. The discordance with other published reports may well reflect differences in 3D versus 2D cultures.
We also looked to see whether notch signaling affected MET, that is, the acquisition of polarity by the EC with subsequent tube formation. Our data show that as EC sprout into fibrin gels, they establish polarity, as shown by collagen IV staining (Fig. 8B) , and generate patent intercellular lumens (Fig. 8A) . However, these processes are independent of notch signaling, as GSI-treated EC still lay down polarized basement membrane and form lumens (Fig. 8) . Our data confirm that EC show plasticity consistent with EMT and MET; however, a clear role for notch is yet to be established.
In summary, we have identified novel roles for notch in regulating patterning of EC tubules, which we believe, have direct relevance to angiogenesis in vivo. In addition to its role in regulating arterio-venous cell fate choices in EC (20, 21) , we show that notch is used reiteratively and acts cell-autonomously to influence EC proliferation and vessel diameter and the phenotype of tip cells. A synthesis of our data and those of others suggests that notch signals interact with growth factor pathways important for angiogenesis. Some of these factors may be EC-derived, such as EGF-like domain 7 (57), or like VEGF, may be derived from support cells. Notch thus represents an important target for therapeutic regulation of EC phenotype. were transfected with Notch1EC-Ig or the empty control vector. Expression of the recombinant protein (40-42 kDa) in the cell extracts and the conditioned medium was confirmed using Western blotting with a horseradish peroxidase-conjugated anti-mouse IgG antibody. B) EC cotransfected with a RBP-luciferase reporter and the Notch1EC-Ig vector or the empty vector were cultured in 2D or 3D collagen gels and assayed for luciferase activity after 18 h. Notch activity is induced in 3D gels and blocked by the dominant-negative protein. *, P < 0.05, for pcDNA3 (2D vs. 3D); **, P < 0.05, for 3D (pcDNA3 vs. N1EC-Ig). C) Notch1EC-Ig inhibits Notch signaling and promotes proliferation. EC were transfected and cultured on beads for 4 days. BrdU staining as in Fig. 3D . *, P < 0.05. D) Inhibition of notch expression promotes proliferation. EC were transfected with the scrambled or the Notch1 or Notch4 antisense oligonucleotides and treated with BrdU at day 4. * and **, P < 0.01 and P < 0.05, respectively. Phase contrast images of sprouts in fibrin gels grown in the presence of DMSO or GSI. Ac, d) Semi-thin cross-sections of vessels are shown, which demonstrate the presence of lumens in treated and untreated cultures. Original scale bars represent 50 µm. Ae, f) The presence of a lumen surrounded by tubulin-positive EC (green); nuclei are counterstained with DAPI (blue). Af) Phase contrast image is used. B). Two-photon fluorescence images of cultures treated with DMSO or GSI demonstrate correct apical-basal polarization for both conditions. Vessels were stained for collagen-IV (green), F-actin (red), and nuclear DNA (DAPI-blue). Original scale bar represents100 µm. C) Two-photon fluorescence images showing polarized collagen-IV staining (green) on the basal surfaces of vessels. Cells were counterstained with DAPI (blue) and β-catenin (red). Note the lack of collagen IV staining around the emerging EC sprout. Original scale bar represents 10 µm.
